Stock Report

IPCA Laboratories Q3FY22 consolidated PAT at Rs. 196.96 crores



Posted On : 2022-02-14 21:58:06( TIMEZONE : IST )

IPCA Laboratories Q3FY22 consolidated PAT at Rs. 196.96 crores

has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 1443.40 crores during the period ended December 31, 2021 as compared to Rs. 1562.51 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 196.96 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 250.23 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 7.76 for the period ended December 31, 2021 as compared to Rs. 9.86 for the period ended September 30, 2021.

Financials Q3 FY2022 Q2 FY2022 % Change
Total Income ₹ 1443.40 crs ₹1562.51 crs Up Tick / Down Tick-7.62%
Net Profit ₹196.96 crs ₹250.23 crs Up Tick / Down Tick-21.29%
EPS ₹7.76 ₹9.86 Up Tick / Down Tick-21.30%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 1443.40 crores during the period ended December 31, 2021 as compared to Rs.1425.21 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.196.96 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.265.47 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.7.76 for the period ended December 31, 2021 as compared to Rs.10.46 for the period ended December 31, 2020.

Financials Q3 FY2022 Q3 FY2021 % Change
Total Income ₹ 1443.40 crs ₹1425.21 crs Up Tick / Down Tick1.28%
Net Profit ₹196.96 crs ₹265.47 crs Up Tick / Down Tick-25.81%
EPS ₹7.76 ₹10.46 Up Tick / Down Tick-25.81%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.4592.72 crores during the 9 Months period ended December 31, 2021 as compared to Rs.4348.25 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.753.85 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.978.67 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.29.71 for the 9 Months period ended December 31, 2021 as compared to Rs. 38.66 for the 9 Months period ended December 31, 2020.

Financials 9 Months Ended FY2022 9 Months Ended FY2021 % Change
Total Income ₹4592.72 crs ₹4348.25 crs Up Tick / Down Tick5.62%
Net Profit ₹753.85 crs ₹978.67 crs Up Tick / Down Tick-22.97%
EPS ₹29.71 ₹ 38.66 Up Tick / Down Tick-23.15%

Source : Equity Bulls

Keywords

IPCALaboratories Q3FY22 9MFY22 ResultUpdate